Boston Partners
LMAT icon

Boston Partners’s LeMaitre Vascular LMAT Stock Holding History

Boston Partners’s Portfolio LMAT Stock Details LMAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-114,830
Closed -$962K – 725
2015
Q1 		$962K Sell
114,830
-4,330
-4% -$34K ﹤0.01% 663
2014
Q4 		$912K Buy
+119,160
New +$853K ﹤0.01% 673

Other funds holding LMAT

AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
CC
Cannell Capital Alta, Wyoming $149M AUM 39.81% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $1.07B AUM 34.04% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Boston Partners's LMAT Position: Q2 2015 in Review

Boston Partners sold out of LeMaitre Vascular (LMAT) in Q2 2015, closing a stake of 114,830 shares — an estimated $962K sold.

Boston Partners first reported a position in LMAT in Q4 2014 and held it in 2 quarters. The position peaked at $962K in Q1 2015. 75 funds tracked by Wall St. Rank hold LMAT as of Q2 2015.

  • Boston Partners reported no remaining LeMaitre Vascular position as of Q2 2015 after selling out during the quarter.
  • Boston Partners sold 114,830 LeMaitre Vascular shares in Q2 2015, an estimated $962K.
  • Boston Partners first reported a position in LeMaitre Vascular in Q4 2014 and held it in 2 quarters.
  • Boston Partners's LeMaitre Vascular position peaked at $962K in Q1 2015.
  • 75 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2015.

Based on Boston Partners's 13F filing for Q2 2015, filed 10 Aug 2015.